Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Cash from Operations (2019 - 2025)

Historic Cash from Operations for Sanofi (SNY) over the last 8 years, with Q4 2025 value amounting to $3.2 billion.

  • Sanofi's Cash from Operations rose 92183.93% to $3.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $15.6 billion, marking a year-over-year increase of 5686.4%. This contributed to the annual value of $12.1 billion for FY2025, which is 2360.31% up from last year.
  • As of Q4 2025, Sanofi's Cash from Operations stood at $3.2 billion, which was up 92183.93% from $8.5 billion recorded in Q3 2025.
  • Sanofi's Cash from Operations' 5-year high stood at $11.3 billion during Q4 2021, with a 5-year trough of -$495.4 million in Q2 2024.
  • For the 5-year period, Sanofi's Cash from Operations averaged around $3.8 billion, with its median value being $2.8 billion (2021).
  • In the last 5 years, Sanofi's Cash from Operations skyrocketed by 971478.51% in 2021 and then tumbled by 15568.12% in 2024.
  • Quarter analysis of 5 years shows Sanofi's Cash from Operations stood at $11.3 billion in 2021, then decreased by 1.17% to $11.2 billion in 2022, then crashed by 84.49% to $1.7 billion in 2023, then plummeted by 81.85% to $315.2 million in 2024, then surged by 921.84% to $3.2 billion in 2025.
  • Its Cash from Operations stands at $3.2 billion for Q4 2025, versus $8.5 billion for Q3 2025 and $1.6 billion for Q2 2025.